pubmed-article:2279734 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2279734 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:2279734 | lifeskim:mentions | umls-concept:C0337611 | lld:lifeskim |
pubmed-article:2279734 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:2279734 | lifeskim:mentions | umls-concept:C0024204 | lld:lifeskim |
pubmed-article:2279734 | lifeskim:mentions | umls-concept:C0021755 | lld:lifeskim |
pubmed-article:2279734 | lifeskim:mentions | umls-concept:C1325847 | lld:lifeskim |
pubmed-article:2279734 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
pubmed-article:2279734 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
pubmed-article:2279734 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:2279734 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:2279734 | pubmed:dateCreated | 1991-3-13 | lld:pubmed |
pubmed-article:2279734 | pubmed:abstractText | Biologically active interleukin-1 (IL-1) has been detected in supernatants of draining lymph node cells isolated from contact-sensitized mice. Induction of IL-1 was dependent upon the concentration of sensitizer applied and occurred within 2 hr of exposure. The IL-1 activity could not be attributed to other interleukins and was neutralized by a specific antiserum. Reduced concentrations of IL-1 were produced by cells isolated from the draining nodes of mice that had been pre-exposed to the sensitizer. Since IL-1 has the potential to influence several aspects of lymphocyte activation, the production of significant concentrations of biologically active IL-1 by draining lymph node cells indicates that it is likely to play an important role in the afferent phase of contact sensitization. | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:language | eng | lld:pubmed |
pubmed-article:2279734 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2279734 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2279734 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2279734 | pubmed:month | Dec | lld:pubmed |
pubmed-article:2279734 | pubmed:issn | 0019-2805 | lld:pubmed |
pubmed-article:2279734 | pubmed:author | pubmed-author:JonesD ADA | lld:pubmed |
pubmed-article:2279734 | pubmed:author | pubmed-author:HumphreysMM | lld:pubmed |
pubmed-article:2279734 | pubmed:author | pubmed-author:KimberII | lld:pubmed |
pubmed-article:2279734 | pubmed:author | pubmed-author:HopkinsS JSJ | lld:pubmed |
pubmed-article:2279734 | pubmed:author | pubmed-author:KinnairdAA | lld:pubmed |
pubmed-article:2279734 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2279734 | pubmed:volume | 71 | lld:pubmed |
pubmed-article:2279734 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2279734 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2279734 | pubmed:pagination | 493-6 | lld:pubmed |
pubmed-article:2279734 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:2279734 | pubmed:meshHeading | pubmed-meshheading:2279734-... | lld:pubmed |
pubmed-article:2279734 | pubmed:meshHeading | pubmed-meshheading:2279734-... | lld:pubmed |
pubmed-article:2279734 | pubmed:meshHeading | pubmed-meshheading:2279734-... | lld:pubmed |
pubmed-article:2279734 | pubmed:meshHeading | pubmed-meshheading:2279734-... | lld:pubmed |
pubmed-article:2279734 | pubmed:meshHeading | pubmed-meshheading:2279734-... | lld:pubmed |
pubmed-article:2279734 | pubmed:meshHeading | pubmed-meshheading:2279734-... | lld:pubmed |
pubmed-article:2279734 | pubmed:meshHeading | pubmed-meshheading:2279734-... | lld:pubmed |
pubmed-article:2279734 | pubmed:meshHeading | pubmed-meshheading:2279734-... | lld:pubmed |
pubmed-article:2279734 | pubmed:meshHeading | pubmed-meshheading:2279734-... | lld:pubmed |
pubmed-article:2279734 | pubmed:meshHeading | pubmed-meshheading:2279734-... | lld:pubmed |
pubmed-article:2279734 | pubmed:meshHeading | pubmed-meshheading:2279734-... | lld:pubmed |
pubmed-article:2279734 | pubmed:year | 1990 | lld:pubmed |
pubmed-article:2279734 | pubmed:articleTitle | Production of interleukin-1 by draining lymph node cells during the induction phase of contact sensitization in mice. | lld:pubmed |
pubmed-article:2279734 | pubmed:affiliation | University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford, U.K. | lld:pubmed |
pubmed-article:2279734 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2279734 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2279734 | lld:pubmed |